| Primary |
| Product Used For Unknown Indication |
45.1% |
| Hypothyroidism |
13.3% |
| Drug Use For Unknown Indication |
8.7% |
| Hypertension |
7.5% |
| Prophylaxis |
2.9% |
| Drug Exposure Via Mother |
2.3% |
| Neck Pain |
2.3% |
| Chronic Myeloid Leukaemia |
1.7% |
| Epilepsy |
1.7% |
| Hypercholesterolaemia |
1.7% |
| Infection |
1.7% |
| Pain |
1.7% |
| Atrial Fibrillation |
1.2% |
| Basedow's Disease |
1.2% |
| Breast Cancer |
1.2% |
| Diabetes |
1.2% |
| Diabetes Mellitus |
1.2% |
| Drug Exposure During Pregnancy |
1.2% |
| Hepatitis C |
1.2% |
| Hypertensive Cardiomyopathy |
1.2% |
|
| Pregnancy |
10.0% |
| Vomiting |
10.0% |
| Hepatitis |
6.7% |
| Hyperthyroidism |
6.7% |
| Neutropenia |
6.7% |
| Overdose |
6.7% |
| Renal Failure Acute |
6.7% |
| Respiratory Disorder |
6.7% |
| Agranulocytosis |
3.3% |
| Arrhythmia |
3.3% |
| Chronic Obstructive Pulmonary Disease |
3.3% |
| Coronary Artery Disease |
3.3% |
| Foetal Death |
3.3% |
| Food Aversion |
3.3% |
| Gastrointestinal Haemorrhage |
3.3% |
| Heart Valve Replacement |
3.3% |
| Hepatic Function Abnormal |
3.3% |
| Hypoglycaemia Neonatal |
3.3% |
| Hypothyroidism |
3.3% |
| Iatrogenic Injury |
3.3% |
|
| Secondary |
| Product Used For Unknown Indication |
21.2% |
| Drug Use For Unknown Indication |
16.9% |
| Hypothyroidism |
11.8% |
| Hypertension |
11.1% |
| Unevaluable Event |
5.8% |
| Prophylaxis |
4.5% |
| Atrial Fibrillation |
3.1% |
| Depression |
3.0% |
| Type 2 Diabetes Mellitus |
2.7% |
| Anxiety |
2.5% |
| Neck Pain |
2.2% |
| Diabetes Mellitus |
2.1% |
| Arrhythmia |
1.9% |
| Cord Blood Transplant Therapy |
1.8% |
| Epilepsy |
1.8% |
| Ischaemic Cardiomyopathy |
1.7% |
| Thrombosis Prophylaxis |
1.7% |
| Hypercholesterolaemia |
1.5% |
| Cytomegalovirus Infection |
1.4% |
| Hypopituitarism |
1.4% |
|
| Pruritus |
9.5% |
| Renal Failure Acute |
9.5% |
| Peritoneal Haemorrhage |
8.6% |
| Lung Disorder |
7.8% |
| Toxic Skin Eruption |
6.9% |
| Transaminases Increased |
5.2% |
| Eosinophilia |
4.3% |
| International Normalised Ratio Increased |
4.3% |
| Pancreatic Carcinoma Metastatic |
4.3% |
| Pulmonary Arterial Hypertension |
4.3% |
| Thrombotic Microangiopathy |
4.3% |
| Headache |
3.4% |
| Osteonecrosis |
3.4% |
| Pyrexia |
3.4% |
| Supraventricular Extrasystoles |
3.4% |
| Thrombocytopenia |
3.4% |
| Tongue Oedema |
3.4% |
| Tooth Abscess |
3.4% |
| Tremor |
3.4% |
| Urticaria |
3.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.6% |
| Drug Use For Unknown Indication |
24.3% |
| Hypothyroidism |
9.1% |
| Hypertension |
8.5% |
| Rheumatoid Arthritis |
3.4% |
| Atrial Fibrillation |
3.2% |
| Depression |
2.7% |
| Pain |
2.7% |
| Hepatitis C |
2.5% |
| Type 2 Diabetes Mellitus |
2.2% |
| Breast Cancer |
2.2% |
| Thyroid Cancer |
2.0% |
| Osteoporosis |
2.0% |
| Epilepsy |
1.7% |
| Prophylaxis |
1.5% |
| Anxiety |
1.4% |
| Diabetes Mellitus |
1.4% |
| Hypercholesterolaemia |
1.3% |
| Insomnia |
1.0% |
| Thrombosis Prophylaxis |
1.0% |
|
| Renal Failure Acute |
11.3% |
| Vomiting |
11.3% |
| Thrombocytopenia |
8.1% |
| Renal Failure |
7.7% |
| Weight Decreased |
5.6% |
| Pyrexia |
5.3% |
| Somnolence |
4.9% |
| Pulmonary Embolism |
4.6% |
| Vertigo |
4.5% |
| Toxic Skin Eruption |
4.3% |
| Malaise |
3.9% |
| Rhabdomyolysis |
3.6% |
| Tremor |
3.6% |
| Orthostatic Hypotension |
3.5% |
| International Normalised Ratio Increased |
3.4% |
| Subdural Haematoma |
3.4% |
| Hyponatraemia |
3.1% |
| Overdose |
2.8% |
| Weight Increased |
2.7% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.5% |
|
| Interacting |
| Hypothyroidism |
24.1% |
| Hepatitis C |
10.3% |
| Atrial Fibrillation |
6.9% |
| Drug Use For Unknown Indication |
6.9% |
| Schizophrenia |
6.9% |
| Breast Cancer |
5.2% |
| Pruritus |
5.2% |
| Thyroid Cancer |
5.2% |
| Basedow's Disease |
3.4% |
| Hypertension |
3.4% |
| Insomnia |
3.4% |
| Pain |
3.4% |
| Type 2 Diabetes Mellitus |
3.4% |
| Arrhythmia |
1.7% |
| Depression |
1.7% |
| Duodenal Ulcer |
1.7% |
| Essential Hypertension |
1.7% |
| Fungal Infection |
1.7% |
| Hypercholesterolaemia |
1.7% |
| Neuropathy Peripheral |
1.7% |
|
| International Normalised Ratio Increased |
17.4% |
| Thyroid Function Test Abnormal |
17.4% |
| Hyperthyroidism |
13.0% |
| Hypothyroidism |
8.7% |
| Renal Failure Acute |
8.7% |
| Toxic Skin Eruption |
8.7% |
| Cough |
4.3% |
| Drug Interaction |
4.3% |
| Liver Function Test Abnormal |
4.3% |
| Orthostatic Hypotension |
4.3% |
| Renal Failure |
4.3% |
| Subdural Haematoma |
4.3% |
|
